UVA Health

Overview

The UVA Health Cancer Center is an NCI-designated Comprehensive Cancer Center and our Stem Cell Transplant Program is FACT accredited. We perform autologous, related/unrelated allogeneic, haploidentical and cord blood transplants in adult patients. We improve lives through outstanding and compassionate transplant and cell therapy. We support our patients, families and team members through a collaborative, diverse community bound by values of empathy, caring, trust, and respect. We improve the lives of future patients through innovative research.

This center has been performing allogeneic transplants since 2012 and has been an NMDP transplant center since April 2014.

Attending physicians

Adult - Karen Ballen, Joseph Clara, Krithika Shanmugasundaram, Indumathy Varadarajan, Leonid Volodin, John Wagner

Transplants performed

Marrow/PBSC and double cord

Cord blood transplants

Adult only

Other programs and services

Nearby affordable suites and hotels offer discounted rates for post-transplant patients. We have a housing assistance program available for low income patients and families, as well as gas and food gift cards avail for emergency use and access to a community food bank. Patients are provided with social work, mental health, and chaplaincy support throughout the process.

Patient survival information for this center

This center's actual 1-year survival results are similar to the expected rate for this center*.

The survival information we have for this center includes ONLY:

Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
Who had their transplant at a U.S. transplant center, and
Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 140 patients.

The actual 1-year survival of these patients is 80%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 69.8% and 83.3%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report

at bloodcell.transplant.hrsa.gov.

* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.

The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.

Total adult transplants

301

Transplants reported by the centers (from January 1, 2022 to December 31, 2023)

	Marrow	PBSC	Cord blood	Total
Allogeneic
Related donor	Marrow 6	PBSC 34	Cord blood 0	Total 40
Unrelated donor	Marrow 2	PBSC 77	Cord blood 0	Total 79
Total allogeneic	Marrow 8	PBSC 111	Cord blood 0	Total 119
Autologous	Marrow Both marrow & PBSC 182	PBSC —	Cord blood —	Total 182
Total combined	Marrow Both marrow & PBSC 301	PBSC —	Cord blood 0	Total 301

All Diseases

Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)

	0-18	19-44	45-64	65+	Total
Related	0-18 0	19-44 12	45-64 20	65+ 8	Total 40
Unrelated	0-18 0	19-44 14	45-64 38	65+ 27	Total 79
Autologous	0-18 1	19-44 21	45-64 95	65+ 65	Total 182
Total	0-18 1	19-44 47	45-64 153	65+ 100	Total 301

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.

Centers are not required to report autologous transplants so the numbers might be incomplete.

More information about transplants can be found:

U.S. Transplant Data by Center (Opens in a new tab)
report at blood cell.transplant.hrsa.gov
List of diseases

Transplant center resources

Transplant center coordinator

April Page

Phone: (434) 305-7672

Email: anf3r@hscmail.mcc.virginia.edu

Financial representative

Martin Braun

Phone: (434) 297-4249

Email: mb6bf@virginia.edu

NMDP patient navigators

Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.

Inside the United States: 1 (888) 999-6743
Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)

Email: patientinfo@nmdp.org

More resources

Choosing a transplant center
Preparing for transplant
Learn about transplant outcomes and treatment decisions (Opens in a new tab)
Support and resources (including non-English materials)
U.S. Transplant Data by Center (Opens in a new tab)
at blood cell.transplant.hrsa.gov

University of Virginia

1215 Lee Street

Charlottesville, VA 22903

Phone:434-924-9333

For more information about this program: http://www.uvastemcell

Staff

Program Director:Karen Ballen, MD

Program Coordinator:Margie Kellison, RN

Medical Specialties in Program

Cardiology, complementary and alternative medicine, dentistry, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.

Medical Services Offered

Chronic GVHD management, fertility counseling, reproductive health, financial counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services, vaccinations.

Telemedicine services are available.

Patient Eligibility

Adults

Allogeneic and Autologous transplant recipients
Adults: 3 months after transplant.
Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
Does accept patients who were transplanted at another hospital

Locations

Transplant Summary